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Letter to the Editor
Leigh Syndrome with atypical cerebellum imaging features
We appreciate the received letter and thank the opportunity to
clarify the issues raised over our article “Leigh Syndrome with atypical
cerebellar lesions” [1].
The cerebellar lesions were interpreted as microbleeds based on
basic MR semiology [2]. Multiple foci of small, rounded, homogeneous,
and markedly hypointense lesions on susceptibility-weighted magnetic
resonance imaging, are extensively described in medical literature and
regarded as microbleeds [2]. This correlation has been demonstrated by
some radiologic-histopathologic studies [3,4], with demonstration of
perivascular hemosiderin deposits [5].
Cerebral microbleeds present most commonly in the elderly popu-
lation, being mostly related to hypertensive arteriopathy and cerebral
amyloid angiopathy [2,6]. However, there are more potential causes,
such as traumatic brain injury [7], posterior reversible encephalopathy
syndrome (PRES) [8], cerebral autosomal dominant arteriopathy with
subcortical infarcts and leukoencephalopathy (CADASIL) [9], Moya-
Moya [10], radiation-induced microbleeds [11]. In most of the pre-
viously stated causes for cerebral microbleeds, an underlying vasculo-
pathy mechanism has been proved or formally proposed [2–7] [8–12].
In most of the patients, the diagnosis is presumptive, based on brain
imaging semiology and other clinical findings, and not on brain biopsy
[2,7].
As substantiated, there are several potential causes for microbleeds,
many of them unrelated to vascular typical adult risk factors. Thus,
stating the absence of the typical adult factors to refute the existence of
microangiopathy is a misconception.
MELAS, MERRF, and LHON are mentioned as a proof of concept that
mitochondrial diseases can present with cerebral microangiopathy, just
like we propose for Leigh Syndrome [12]. The patient has a genetically
proven Leigh Syndrome [1]; thus, there is no point in refuting symp-
toms related to other mitochondrial diseases that the index patient does
not have.
The index patient is alive and has a genetically proven Leigh
Syndrome [1]. A biopsy has no clinical purpose and would be unethical.
The figures reported by Muramatsu et al. [13] reinforce our re-
commendation of considering mitochondrial disease in the differential
diagnosis of an acute cerebellar disease.
Ischemic stroke is not mentioned in the article. In fact, brain par-
enchymal restricted diffusion has been demonstrated in several dif-
ferent brain pathologies, distinctive of ischemic stroke [14]. Panels G
and H from Fig. 1 show a pattern of restricted diffusion [1], which has
been demonstrated in basal ganglia and thalami of Leigh Syndrome
patients [15]. Perfusion imaging had no clinical indication.
As stated in the article, cytotoxic edema exists when there is a
pattern of restricted diffusion, which is defined by ADC hypointensity.
ADC is represented by a graphic reconstruction obtained by plotting the
natural logarithm of the signal intensity versus two b values (b = 0 s/
mm2 and b = 1000 s/mm2) [16] and is not a matter of the authors'
opinion.
The patient did not present with stroke-like episode.
Our focus in this case report is the brain lesions since they probably
underlie all the major clinical findings. On a formal neurologic ex-
amination, muscle weakness was not prominent and had not a proximal
to distal gradient. The patient is thin, and the muscles are globally and
moderately hypotonic, with retained reflexes. EMG was performed and
demonstrated signs of mild denervation consistent with axonal neuro-
pathy. In Leigh syndrome this finding is not very uncommon and is
usually a subclinical problem [17,18]. Therefore, we used the term
muscular hypotrophy, not atrophy.
We hope our answer was useful.
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